2017 annual financial data

Aytu BioPharma 2017 Financial results

Direct answer

Revenue was 3,221,590 USD.

Operating income was -20,125,236 USD and net income was -22,508,304 USD.
Operating cash flow was -13,829,652 USD.

Get free Aytu BioPharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3,221,590 USD
Operating income
-20,125,236 USD
Net income
-22,508,304 USD
Operating cash flow
-13,829,652 USD